Chronic Myeloid Leukemia

Häftad, Engelska, 2022

1 149 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health.

Produktinformation

Utgivningsdatum2022-06-04
Mått178 x 254 x 15 mm
Vikt604 g
FormatHäftad
SpråkEngelska
SerieHematologic Malignancies
Antal sidor273
Upplaga2
FörlagSpringer Nature Switzerland AG
ISBN9783030719159

Tillhör följande kategorier

Onkologi inom Medicin
Hematologi inom Medicin

Rüdiger Hehlmann is a Professor of Medicine at the Mannheim Medical Faculty of the University of Heidelberg, Germany. Founder and Chair, European LeukemiaNet (ELN)Founder and chair of the German CML Study Group 1982-2017Former Secretary GeneralInternational Association of Comparative Research on Leukemia & Related Diseases (IACRLRD)Former Chief of Medicine, Dean & PresidentGerman Society of Hematology and OncologyHonorary member of the Polish and German Societies for Hematology and OncologyCurrent focus: promotion of cooperative research for curing leukemia

Cytogenetics of Chronic Myeloid Leukemia (CML).- The Biology and Pathogenesis of Chronic Myeloid Leukaemia.- Epidemiology of Chronic Myeloid Leukemia.-Imatinib and the first line CML Therapy.- CML Therapy: A Focus on Second and Third Generation Tyrosine Kinase Inhibitors.- Adverse events associated with ATP-competitive BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia.- Pharmacoeconomic considerations for tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.- Standardization of molecular monitoring for chronic myeloid leukemia: 2021 update.- Prognostic Scores for Patients with Chronic Myeloid Leukemia under Particular Consideration of Disease-Specific Death.- A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia.- The Role of Hematopoietic Stem Cell Transplantation in CML.- CML end-phase and blast crisis: implications and management.- The Interferon-alpha Revival in CML.- Managing Pregnancy in Chronic Myeloid Leukemia.- Response-Related Predictors of Survival and of Treatment Free Remission in CML.- Discontinuation or cessation of tyrosine kinase inhibitor treatment in Chronic myeloid leukemia patients with deep molecular response.